Gastrointestinal Stromal Tumor (GIST) Drug Market Industry: Future Demand, Market Analysis & Outlook to 2022
A new and latest research report proposed by QY Research Groups renders a market summary of the Gastrointestinal Stromal Tumor (GIST) Drug Market industry. This widespread analysis comprises of market potentials.
(EMAILWIRE.COM, December 15, 2017 ) In this report, the global Gastrointestinal Stromal Tumor (GIST) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Sample Copy of This Report: https://www.qyresearchgroups.com/request-sample/651583
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug in these regions, from 2012 to 2022 (forecast), covering:
North America
Europe
China
Japan
Southeast Asia
India
Global Gastrointestinal Stromal Tumor (GIST) Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including:
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
Detailed TOC: https://www.qyresearchgroups.com/report/global-gastrointestinal-stromal-tumor-gist-drug-market-research-report-2017
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into:
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including:
Clinic
Hospital
Others
Table of Contents -
2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Manufacturers
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
2.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
2.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion….
7 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Profiles/Analysis
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification….
8 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost Analysis
8.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug….
Get Discount on this Report: https://www.qyresearchgroups.com/check-discount/651583
About Us:
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on Global industries, companies, products, and trends.
Sample Copy of This Report: https://www.qyresearchgroups.com/request-sample/651583
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug in these regions, from 2012 to 2022 (forecast), covering:
North America
Europe
China
Japan
Southeast Asia
India
Global Gastrointestinal Stromal Tumor (GIST) Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including:
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
Detailed TOC: https://www.qyresearchgroups.com/report/global-gastrointestinal-stromal-tumor-gist-drug-market-research-report-2017
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into:
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including:
Clinic
Hospital
Others
Table of Contents -
2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Manufacturers
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
2.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
2.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion….
7 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Profiles/Analysis
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification….
8 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost Analysis
8.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug….
Get Discount on this Report: https://www.qyresearchgroups.com/check-discount/651583
About Us:
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on Global industries, companies, products, and trends.
Contact Information:
QYResearch Groups
John
Tel: +1-888-236-2744
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
QYResearch Groups
John
Tel: +1-888-236-2744
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results